Despite its prevalence, a significant number of non-valvular atrial fibrillation (NVAF) cases remain undiagnosed, putting patients at risk for cardiovascular complications, including heart failure, left ventricular dysfunction, hypertension, diabetes, stroke or embolism, and vascular disease. Primary care physicians face challenges in identifying and managing NVAF, and often fail to implement guideline-concordant care due to a lack of awareness of patients who could benefit from therapy, or lack of confidence in utilizing these therapies. In addition, patients from communities of color often do not receive the same level of care as those from other populations, while new and emerging technologies, such as smart watches, portable ECG devices, and medication/fitness trackers can both enhance patient engagement in care and create clinical quandaries for practitioners.
During this 60-minute Live and OnDemand webcast, an interprofessional panel of experts including a cardiologist, a PCP, and a digital health specialist provide astute perspectives on how to implement equitable and contemporary NVAF screening and management strategies into clinical practice.
At the end of this CME/CE activity, participants should be able to:
Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.
Primary care clinicians, nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists and other clinicians who help care for patients with CVD
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Kountz reports the following financial relationships: Research Support: National Heart, Lung, and Blood Institute (NHLBI).
Dr. Cho has no financial relationships to disclose.
Dr. Ko reports the following financial relationships: Consultant: Eagle Pharmaceuticals, Inc. Research Support: Investigator initiated research from Boston Scientific Corporation
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.